Intervention: bortezomib, dexamethasone, and thalidomide
Found 54 matching trials
A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma
PHASE1
The purpose of this study is to evaluate the safety, tolerability, and dose...
A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple Myeloma
PHASE2
The purpose of this Phase 2 randomized study is to evaluate the efficacy an...
Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
PHASE1
RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide and dexamet...
S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia
PHASE2
RATIONALE: Sometimes the cancer may not need treatment until it progresses....
Status
Withdrawn
Location
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center